A newly surfaced internal memo from the U.S. Food and Drug Administration (FDA) has sparked debate after chief medical and scientific officer Vinay Prasad stated that COVID-19 vaccinations may have contributed to at least 10 cases of fatal heart inflammation in children. According to the memo, seen by Reuters, Prasad said the staff’s preliminary review suggested “likely, probable, or possible” vaccine attribution in these deaths. He described the findings as significant, noting it would mark the first time the FDA acknowledged potential fatal vaccine-related cases in American children.
The analysis reviewed 96 child deaths reported between 2021 and 2024. While it did not identify the children’s underlying medical conditions or the vaccine manufacturers involved, Prasad said that the early assessment found no fewer than 10 cases potentially linked to COVID-19 vaccination. He added that examining deaths involving children aged 7 to 16 was especially difficult.
Health Secretary Robert F. Kennedy Jr. has recently shifted U.S. vaccine policy, restricting access to COVID-19 vaccines to individuals 65 and older and those with certain conditions. Kennedy, long known for his skepticism toward vaccines, has criticized past vaccine policies promoted under both the Trump and Biden administrations.
Experts have urged caution in interpreting the memo. The FDA’s assessment has not been peer-reviewed or published in a medical journal, and critics—including UC Law San Francisco professor Dorit Reiss—argue that policy changes should not stem from unpublished investigations. Reiss also noted Prasad is not a vaccine specialist.
Despite concerns raised in the memo, FDA Commissioner Marty Makary emphasized that COVID-19 vaccines were highly effective for older adults, especially when matched to circulating variants. Recent research also supports the benefits of updated vaccines in reducing severe illness and hospitalization among high-risk groups.
CDC data shows 1,071 U.S. children aged 5 to 18 died from COVID-19 between early 2020 and mid-2023. Prasad argued that it remains unclear how vaccination influenced those outcomes, stating that voluntary reporting and unknown prevention metrics complicate comparisons.
The memo is expected to fuel continued discussion ahead of an upcoming CDC vaccine committee meeting.


Russian LNG Shadow Fleet Expands Amid Arctic LNG 2 Sanctions
Rubio Presses Italy Over Iran Support as Tensions Test U.S.-Italy Alliance
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
China-Made Fireworks Power U.S. Independence Day Celebrations Amid Trade Truce
Judge Rules DOGE Humanities Grant Cuts Unconstitutional
Pope Leo Calls for Peace as Vatican Seeks Better Ties With U.S.
UN Experts Condemn Trump’s Cuba Fuel Blockade Amid Deepening Energy Crisis
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
U.S. Flags Vietnam as “Priority Foreign Country” Over Intellectual Property Concerns
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Trump Inspects Lincoln Memorial Reflecting Pool Renovation in Washington
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Russia Downs Over 50 Drones Near Moscow Ahead of Victory Day Ceasefire 



